Alpha Tau Medical Stock Forecast

Stock Price Forecast

According to 5 analysts polled by S&P Global, Alpha Tau Medical stock has a consensus rating of "Buy" and an average price target of $14.2. The average 1-year stock price forecast is 30.51% higher than the current stock price, while the lowest is $8.00 (-26.47%) and the highest is $17 (+56.25%).

Price Target: $14.2 (+30.51%)

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$8.00	$14.2	$15	$17
Change	-26.47%	+30.51%	+37.87%	+56.25%

Analyst Ratings

The average analyst rating for Alpha Tau Medical stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Jan '26	Feb '26	Mar '26	Apr '26	May '26	Jun '26
Strong Buy	3	3	3	3	3	3
Buy	1	1	0	0	1	1
Hold	0	0	1	1	1	1
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	4	4	4	4	5	5

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Yi Chen H.C. Wainwright	H.C. Wainwright	Buy Reiterates $15	Buy	Reiterates	$15	+37.87%	Jun 15, 2026
Lukas Shumway Barclays	Barclays	Buy Maintains $15 → $17	Buy	Maintains	$15 → $17	+56.25%	Jun 4, 2026
Jason Bednar Piper Sandler	Piper Sandler	Hold Reiterates $5 → $8	Hold	Reiterates	$5 → $8	-26.47%	May 19, 2026
Jeffrey Cohen Ladenburg Thalmann & Co.	Ladenburg Thalmann & Co.	Buy Reiterates $14	Buy	Reiterates	$14	+28.68%	May 12, 2026
Yigal Nochomovitz Citi	Citi	Buy Reiterates $7 → $9	Buy	Reiterates	$7 → $9	-17.28%	Mar 11, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

1.63M

Revenue Next Year

12.38M

from 1.63M

658.10%

from 1.63M

EPS This Year

-0.66

from -0.53

EPS Next Year

-0.51

from -0.66

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	-	-	-	-	-	1.63M
Operating Income	-13.79M	-32.14M	-35.68M	-36.04M	-42.29M	-51.91M
EPS	-	-	-	-	-0.53	-0.66
Free Cash Flow	-7.53M	-14.62M	-19.40M	-12.97M	-19.70M	-95.00M
No. Analysts	-	-	-	-	-	3

EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue	2026	2027	2028
High	3.2M
Avg	1.6M
Low	n/a

Revenue Growth

Revenue Growth	2027	2028
High	1,699.6%
Avg	658.1%
Low	-100.0%

EPS Forecast

EPS	2026	2027	2028
High	-0.61
Avg	-0.66
Low	-0.69

EPS Growth

EPS Growth	2026	2027	2028
High	-
Avg	-
Low	-